Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
about
Measurable residual disease testing in acute myeloid leukaemia.Current Management of Childhood Acute Myeloid Leukemia.The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.Acid ceramidase is upregulated in AML and represents a novel therapeutic target.The complexity of interpreting genomic data in patients with acute myeloid leukemia.Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemiaDetailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice.Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Prognostic impact of MYH9 expression on patients with acute myeloid leukemia.Discovery of a novel Nrf2 inhibitor that induces apoptosis of human acute myeloid leukemia cellsThe clonal origins of leukemic progression of myelodysplasia.High-throughput sequencing for noninvasive disease detection in hematologic malignancies.Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.Aminoisoquinoline benzamides, FLT3 and Src-family kinase inhibitors, potently inhibit proliferation of acute myeloid leukemia cell lines.Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.What Is the Optimal Induction Therapy for Younger Fit Patients With AML?Acute Myeloid Leukemia: How Do We Measure Success?Alternative roles for oxidized mCs and TETs.Molecular landscape in acute myeloid leukemia: where do we stand in 2016Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia.Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia.Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection.Acute myeloid leukaemia genomics.Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.Cohesin complex is a major player on the stage of leukemogenesis.MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis.The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia.DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML.Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient.Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells.High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy.A 17-gene stemness score for rapid determination of risk in acute leukaemia.OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies.Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.STK3 is a therapeutic target for a subset of acute myeloid leukemias.
P2860
Q30234914-30836AB4-09EF-4CB3-AAE5-FC12A015F7ECQ30244036-EBFAEEC0-0C64-4D1F-BCE8-BD816CEB3867Q30252512-C9526744-3366-4462-A74C-D0CD92B42C7AQ30275460-0F3106C8-619F-4A57-ABA0-EE978919870BQ31149503-16BD8130-11AE-45B2-894F-5E690E2DE2EDQ33774508-2578E0F3-F6E9-4C34-9672-651963742206Q33795203-2BF0D441-A230-44A9-906C-BC72533E06FDQ37330840-9BA6EE33-5671-45A9-87BE-601DE3617473Q37349113-B0579E58-9B82-4862-A947-B450C0102403Q37624593-85084805-BCD8-4C8D-B3F7-A5C5931018DAQ37702129-E2EDB6EC-E297-4D80-9A71-B1999CD55B18Q37702583-CF462A23-F147-4BA7-AA00-AF54D5048CF1Q38406756-FC7C38C9-A5B9-4A22-AA02-FABBB2CE9F95Q38672646-26EA4413-0783-4CB3-972B-6546BDCEFFA1Q38674045-451E7BF5-1AF2-43E5-89A3-E74AE62388F0Q38685553-E331D100-6CC5-4C55-9D4C-8D18B9F80773Q38755213-EE6DBF4F-CCA3-4846-85C5-2A091B99B989Q38892311-2FF41197-0F0B-4E54-9673-10D524B381ECQ38913554-EFABB400-1C94-4E7D-BEC6-6BEE2733C8C5Q38948650-F0F9A6D7-6F6B-4F32-9ECC-EFDE1D9AB287Q39035029-01791C6D-7BA3-4D28-8C4C-E67ED82402CDQ39116878-18A063C4-E7E6-44FB-8FC3-7CC096191DDBQ39135620-49771600-C48A-4995-B7B5-97B1DFB4A3FCQ39235100-9AC0F58F-051E-47FF-B75F-F3B18F55443FQ39264807-B376FB3F-B03F-4932-B339-29D594B81E74Q39400164-020DD4F5-BA25-4D5D-AF14-E276D257D2BAQ40150370-A73C5E24-EFAF-4D1B-B924-381608FC68CDQ40525341-578B4728-F244-4C50-8582-9257C711DAB2Q42407713-32BAC1C6-B0E1-4EC9-82F1-C29497CFF744Q47100861-89351B39-E96F-4904-A100-30BD5B487A6EQ47804815-DED2EFB5-67E3-4612-8530-E203A08BD673Q48255315-51BEF79C-0FB6-4118-AA11-717097EF8759Q48355093-217E3B6B-B148-42A3-9B29-14AD25298546Q48880601-6EA9C0ED-8CB6-4B72-8692-0B25A12B151BQ49615274-4E8239A2-2E20-44F4-A3FF-EFFB4148F355Q50538514-C5639751-E126-4FB7-8065-21CD055A5CB0Q51134492-CE92E986-3028-4B3B-92AB-EEF9326FCD4FQ52347210-B830A0AA-672F-4B19-B794-70CE1F9B62CCQ52718151-ACBB25FD-FD2F-44E2-9BB6-6AEB54F65B47Q54976846-85948A6B-883C-46EE-A095-36C93273397C
P2860
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Molecular landscape of acute m ...... lts and its clinical relevance
@ast
Molecular landscape of acute m ...... lts and its clinical relevance
@en
Molecular landscape of acute m ...... lts and its clinical relevance
@nl
type
label
Molecular landscape of acute m ...... lts and its clinical relevance
@ast
Molecular landscape of acute m ...... lts and its clinical relevance
@en
Molecular landscape of acute m ...... lts and its clinical relevance
@nl
prefLabel
Molecular landscape of acute m ...... lts and its clinical relevance
@ast
Molecular landscape of acute m ...... lts and its clinical relevance
@en
Molecular landscape of acute m ...... lts and its clinical relevance
@nl
P2860
P3181
P1433
P1476
Molecular landscape of acute m ...... lts and its clinical relevance
@en
P2093
David Grimwade
P2860
P3181
P356
10.1182/BLOOD-2015-07-604496
P407
P50
P577
2015-12-10T00:00:00Z